Cannabis is a plant and a class B drug. It affects people differently. It can make you feel relaxed and chilled but it can also make you feel sick, affect your memory and make you feel lethargic. CBD oil is a chemical found in cannabis.
A drug called dexanabinol which is a man made form of a chemical similar to that found in cannabis has been trialled in a phase 1 trial. This is an early trial that tries to work out whether or not the drug works in humans, what the correct dose is and what the side effects might be. The results are not available yet. You can read about the trial on our clinical trials database.
What are cannabis and cannabinoids?
Cannabinoids have helped with sickness and pain in some people.
THC is a psychoactive substance that can create a ‘high’ feeling. It can affect how your brain works, changing your mood and how you feel.
We don’t know yet whether cannabis, or any of the chemicals in cannabis, are useful to treat cancer. But it’s an important topic to discuss. And because we believe in the power of research, we dug into the science to answer some of the top questions you might have on cannabis and its effect on cancer.
There is some evidence that CBD oil could be effective against some rare childhood epilepsies. But again, more data is needed before we can draw any firm conclusions. Studies also show that CBD oil could be beneficial for managing anxiety and insomnia in some people, and early research also suggests a possible use of CBD for the treatment of certain types of pain.
Watch the video:
This is why research and regulated clinical trials are so important. They enable us to make informed decisions on what treatments are likely to work best based on solid evidence.
There is no evidence that CBD oil can be used to treat cancer in people. CBD does show promise for the management of some cancer related symptoms, including pain and anxiety, however, more research into appropriate amounts of CBD and its effects on humans is necessary.
The problem with these stories is that it’s difficult to know whether you have all of the facts. It’s impossible to make any kind of judgement without knowing about the type of cancer, other treatment and the person’s medical history.
CBD is 1 of the hundreds of chemicals found in the flowering cannabis plant. CBD does not have the psychoactive, or mind-altering, effects of another chemical found in cannabis called tetrahydrocannabinol (THC). THC is the chemical that causes people to experience a “high.” CBD, on the other hand, is being used by some to help ease pain, anxiety, and sleep issues.
To date, no large-scale studies have shown CBD to have benefits for the treatment of people with cancer. Most studies that have been done evaluating CBD as a cancer treatment were in mice or in human cells in the lab. For instance, there are some studies that have shown that CBD inhibits the growth of cancer cells in mice with lung cancer or colon cancer. Another study showed that CBD, together with THC, killed glioblastoma cancer cells in the lab. However, no studies have been conducted in people with cancer.
What is CBD?
There is currently 1 CBD treatment approved by the U.S. Food and Drug Administration (FDA) called Epidiolex, which is used to treat a rare and severe form of epilepsy in children. There are not currently any FDA-approved CBD medications for treating cancer or side effects of cancer treatments.
CBD comes from cannabis plants called hemp that are specifically grown with high levels of CBD and low levels of THC. Cannabis plants grown with high levels of THC are usually called marijuana. CBD comes from oil that is extracted from the cannabis plant. That oil can then be ingested as a liquid, a capsule, a gummy, or inhaled through vaping. It can also be added as an ingredient in such products as lotions and skin patches.
There is much about CBD that is still unknown. It has largely gone unstudied because, until 2018, it was considered a schedule I drug by the U.S. Drug Enforcement Administration (DEA). A schedule I drug is a drug that has been declared illegal by the DEA because of safety concerns over its potential for abuse and because there is no accepted medical use for it. Then, in September 2018, the DEA updated CBD’s status to become a schedule V drug. Schedule V drugs have a lower potential for abuse and are deemed to have some medical use.